Aggiornamento
Le infezioni respiratorie ricorrenti
Recurrent respiratory tract infections
Dante Ferrara1,2, Maria Chiara Vella2
1Pediatra di famiglia, Palermo
2Scuola di Specializzazione in Pediatria, Università di Palermo
Febbraio 2020 - pagg. 85 -91
Abstract
Recurrent respiratory tract infections (RRI) constitute an important public health problem,
they are among the main causes of morbidity in paediatric age and one of the most frequent
reasons for prescribing antibiotics. Their management has a significant impact on
the children’s quality of life and their families, as well as on direct and indirect health
costs. It seems that the main strategy to reduce the risk, the number of episodes of RRI
and therefore their impact on children, families and society, is prevention that is based
on the communication with parents and on the elimination/reduction of risk factors. Immunomodulants/
immunostimulants (IM), whose use is widely discussed in the literature,
can be useful in specific cases of difficult family management of children with RRI.
Parole chiave
Suggerite dall'AI
Classificazione MeSH
Contenuto riservato
Per leggere l'articolo completo è necessario effettuare il login.
Non sei ancora registrato? Registrati
Bibliografia
1. Heikkinen T, Järvinen A. The common
cold. Lancet 2003;361(9351):51-9.
2. Terracciano L. Le infezioni respiratorie ricorrenti:
vale ancora la pena parlarne? RIAIP
2008;2:12-9.
3. Fiore M, Napoleone E, Careddu D, et al.
Le infezioni respiratorie ricorrenti. I Consigli
della FIMP. Il Medico Pediatra 2010;3:9-19.
4. Jesenak M, Ciljakova M, Rennerova Z, et
al. Recurrent respiratory infections in children
- Definition, diagnostic approach, treatment
and prevention. 2011.
5. De Martino M, Vierucci A. Il bambino con
infezioni respiratorie ricorrenti. Immunol Pediatr
1981;1:76-9.
6. AIFA. L’uso degli antibiotici in Italia. Rapporto
Nazionale AIFA anno 2017. Febbraio
2019.
7. NICE Clinical Guidelines. Respiratory
tract infections: prescribing antibiotic. Centre
for Clinical Practice NICE (UK). London:
National Institute for Health and Clinical Excellence
(UK), 2008.
8. Goggin K, Bradley-Ewing A, Myers AL, et
al. Protocol for a randomised trial of higher
versus lower intensity patient-provider communication
interventions to reduce antibiotic
misuse in two paediatric ambulatory clinics
in the USA. BMJ 2018:8(5):1.
9. Köchling A, Löffler C, Reinsch S, et al. Reduction
of antibiotic prescriptions for acute
respiratory tract infections in primary care: a
systematic review. Implement Sci 2018;13
(1):47.
10. Aabenhus 1, Jensen JU, Jørgensen KJ,
Hróbjartsson A, Bjerrum L. Biomarkers
point-of-care tests to guide prescription of antibiotics
in patients with acute respiratory infections
in Primary Care. Cochrane Database
Syst Rev 2014;(11):CD010130.
11. Farneti C, Vieni G, Marchetti F. La radiografia
del torace nella broncopolmonite: inutile
nella maggioranza dei casi? Medico e
Bambino 2018;37(2):93-5.
12. Fiore M. OM-85 e prevenzione delle infezioni
respiratorie ricorrenti. Pediatria Preventiva
e Sociale 2018;13(3).
13. De Martino M, Ballotti S. The child with
recurrent respiratory infections: normal or
not? Pediatr Allergy Immunol 2007;18(Suppl
18):13-8.
14. Li Volti G, Malaponte G, Bevelacqua V, et
al. Persistent high plasma levels of interleukins
18 and 4 in children with recurrent
infections of the upper respiratory tract.
Transplant Proc 2003;35:2911-5.
15. Marchisio P. Infezioni respiratorie ricorrenti:
immunomodulanti, dalla ricerca alla
pratica clinica. XI Congresso Nazionale
FIMP, 2017.
16. Jeffrey Modell Foundation. htpp://www.
info4pi.org.
17. Di Sessa A, Nappi F, Marzullo P, Barbi E.
Come si usa il paracetamolo. Medico e Bambino
2014;33(7):451-8.
18. Working Group Pediatrico dell’AIFA.
Cautele sull’uso dei FANS nei bambini. Medico
e Bambino 2010;29(10):654-6.
19. Miceli Sopo S, Monaco S, Greco M, Varrasi
G, Simone G. Tosse acuta e miele. Medico
e Bambino 2014;33(1):41-6.
20. Marchetti F, Panizon F. Infezioni delle vie
respiratorie e antibiotico: sì, no, quando? Medico
e Bambino 2010;29(9):577-84.
21. de Benedictis FM, Franceschini F, Budassi
R, et al. I corticosteroidi nelle malattie
respiratorie: certezze e dubbi 60 anni dopo
(Seconda parte). Medico e Bambino
2012;31(10):652-9.
22. Fiore M, Napoleone E, Careddu D, et al.
Le infezioni respiratorie ricorrenti. I consigli
della FIMP. Il Medico Pediatra 2010;3:9-19.
23. Cardinale F, Bergamini M, Bernardini R,
et al; Gruppo di Studio sugli Immunomodulanti
della SIAIP. Gli immunomodulanti nella
prevenzione delle infezioni respiratorie del
bambino: un approccio EBM. RIAP 2015;suppl
1:1-58.
24. Namazova-Baranova LS, Alekseeva AA,
Kharit SM, et al. Efficacy and safety of pidotimod
in the prevention of recurrent respiratory
infections in children: a multicentre
study. Int J Immunopathol Pharm 2014;27
(3):413-9.
25. Mameli C, Pasinato A, Picca M, Bedogni
G, Pisanelli S, Zuccotti GV; AX-Working
Group. Pidotimod for the prevention of acute
respiratory infections in healthy children entering
into day care: a double blind randomi2015;97:79-83.
26. Esposito S, Garziano M, Rainone V, et al.
Immunomodulatory activity of pidotimod administered
with standard antibiotic therapy
in children hospitalized for community-acquired
pneumonia. J Transl Med 2015;13:288.
27. Hao Q, Dong BR, Wu T. Probiotics for
preventing acute upper respiratory tract infections.
Cochrane Database Syst Rev 2015;
(2):CD006895.
28. Esposito S, Soto-Martinez ME, Feleszkoc
W, et al. Non specific immunomodulators for
recurrent respiratory tract infections, wheezing
and asthma in children: a systematic review
of mechanistic and clinical evidence.
Curr Opin Allergy Clin Immunol 2018;18:198-
209.
29. Schaad UB, Mütterlein R, Goffin H; BVChild
Study Group. Immunostimolation with
OM-85 in children with re-current infections
of the upper respiratory tract: a double-blind,
placebo-controlled multicentre study. Chest
2002;122(6):2042-9.
30. Razi CH, Harmancı K, Abacı A, et al. The
immunostimulant OM-85 BV prevents wheezing
attacks in preschool children. J Allergy
Clin Immunol 2010;126(4):763-9.
31. Yin J, Xu B, Zeng X, et al. Broncho-
Vaxom in pediatric recurrent respiratory
tract infections: a systematic review and meta-
analysis. Int Immunopharmacol 2018;54:
198-209.
32. Marchisio P, Consonni D, Baggi E, et al.
Vitamin D supplementation reduces the risk
of acute otitis media in otitis-prone children.
Pediatr Infect Dis J 2013;32(10):1055-60.
33. Martineau AR, Jolliffe DA, Hooper RL, et
al. Vitamin D supplementation to prevent
acute respiratory tract infections: systematic
review and meta-analysis of individual participant
data. BMJ 2017;356:i6583.
34. Aglipay M, Birken CS, Parkin PC, et al.
Effect of high-dose vs standard-dose wintertime
vitamin D supplementation on viral upper
respiratory tract infections in young healthy
children. JAMA 2017;318(3):245-54.
35. Vorilhon P, Arpajou B, Vaillant Roussel
H, Merlin E, Pereira B, Cabaillot A. Efficacy
of vitamin C for the prevention and treatment
of upper respiratory tract infection. A metaanalysis
in children. Eur J Clin Pharmacol
2019;75(3):303-11.
36. Karsch-Völk M, Barrett B, Kiefer D,
Bauer R, Ardjomand-Woelkart K, Linde K.
Echinacea for preventing and treating the
common cold. Cochrane Database Syst Rev
2015;(2):CD000530.
37. Anheyer D, Cramer H, Lauche R, Saha F J,
Dobos G. Herbal Medicine in children with respiratory
tract infection: systematic review and
meta-analysis. Acad Pediatr 2018;18(1)8-19.
38. Forastiere F, Lo Presti E, Agabiti N.
Health impact of exposure to environmental
tobacco smoke in Italy. Epidemiol Prev 2002;
26:18-29.
39. Liotta G, Ferlisi A, Malizia V. Esposizione
a fumo di sigarette nel bambino e rischio di
allergia: cosa sappiamo? RIAIP 2011;4:22-30.
40. Brugha R, Grigg J. Urban air pollution
and respiratory infections. Paediatr Respir
Rev 2014;15(2):194-9.
41. Allan GM, Arrol B. Prevention and treatment
of the common cold: making sense of
the evidence. CMAJ 2014;186:190-9.
42. Mc Guiness SL, Barker SF, O’Toole J, et
al. Effect of Hygiene interventions on acute
respiratory infections in childcare, school
and domestic settings in low-and middle-income
countries: a systematic review. Trop
Med In the Health 2018;23(8):816-33.
43. Victora CG, Bahl R, Barros AJ, et al.; Lancet
Breastfeeding Series Group. Breastfeeding
in the 21st century: epidemiology, mechanisms,
and life long effect. Lancet 2016;
387(10017):475-90.
44. Ghosh MK, Nguyen V, Muller HK, et al.
Maternal milk T cells drive development of
transgenerational Th1 immunity in off spring
thymus. J Immunol 2016;197(6):2290-6.
Corrispondenza: ferraradnt@libero.it